Edwarda M Buda-Okreglak

  • Citations Per Year
Learn More
Acute adverse reactions to rituximab treatment have been previously described in association with initiation of therapy. We describe a novel delayed proinflammatory syndrome which occurred at, or near, the completion of a 4-week dose-intense course with rituximab in a 58-year-old man with Waldenstrom's macroglobulinemia, and which mimicked acute rheumatoid(More)
References 1 Primbs GB, Monsees WE, Irvine AR. Intraocular Hodgkin’s disease. Arch. Ophthalmol 1961; 66: 477–482. 2 Brihaye-van Geertruyden M. Retinal lesions in Hodgkin’s disease. Arch Ophthalmol 1956; 56: 94–99. 3 Barr CC, Joondeph HC. Retinal periphlebitis as the initial clinical finding in a patient with Hodgkin’s disease. Retina 1983; 3: 253–257. 4(More)
  • 1